Capabilities
End-to-end peptoid CDMO services.
Process development to GMP commercial supply, with the most advanced regulatory program in the category.
03 — Regulatory
The most advanced peptoid program at the FDA.
Most peptoid programs sit in academic preclinical. Ours has moved through the FDA further than any other in the category.
Stage 01
Preclinical
GLP tox package complete.
Cleared
Stage 02
Pre-IND / FDA Type B meeting
Briefing package accepted; meeting held.
Cleared
Stage 03
IND filing / active engagement
Currently under FDA review.
In progress
Stage 04
First-in-human, Phase 1
Sites identified, protocol drafted.
Planned
Stage 05
Phase 2 / 3 / registration
Future development pathway.
Future
Let's discuss your peptoid program.
Tell us where you are. We'll send back the right path to scale, the right experts, and the right paperwork.